(Press-News.org) A new study of more than 2,900 patients provides evidence that it’s likely best to use as little corticosteroid medicine as possible when treating people who have lupus pericarditis, a common heart complication of the autoimmune disease Systemic Lupus Erythematosus (SLE).
This study, funded by the National Institutes of Health’s (NIH) National Heart, Lung, and Blood Institute (NHLBI) and led by Johns Hopkins Medicine cardiologists and rheumatologists who led the study say their analysis of data affirms that using steroids to curb heart inflammation and other painful symptoms for lupus patients is also a risk factor for recurring pericarditis, a potentially dangerous inflammation of the saclike membrane that encases and protects the heart.
Results of this study were published in the February 25th addition of JAMA Network Open
According to the American Heart Association, pericarditis is defined as inflammation of the pericardium, a sac-like structure with two thin layers of tissue that surround the heart to hold it in place and help protect it. Pericarditis typically presents as chest pain that can be exacerbated by lying flat and improved by leaning forward. This pain can last anywhere from a few days to several months. Treatment options for pericarditis include use of colchicine — an anti-inflammatory medication that prevents the recurrence of pericarditis — and corticosteroids.
Pericarditis occurs in 15% to 30% of patients with SLE, a chronic autoimmune disease that causes the body's immune system to attack its own tissues. “It is well known that, in the general population, one fifth of patients who experience pericarditis end up experiencing one or more recurrences. Surprisingly, even though pericarditis is the most common cardiac complication of Lupus, we could not find any information on recurrent of pericarditis in this patient population,” says Dr. Luigi Adamo, M.D., P.H.D., director of Cardiac Immunology at Johns Hopkins University and co-senior author of this study.
Researchers set out to address this gap in knowledge and examine the risk factors contributing to the recurrence.
For the new analysis, researchers used data gathered among the Hopkins Lupus Cohort, a large ongoing study group that includes information on 2,931 patients diagnosed with SLE between 1988 to 2023 and the investigators focused on data from 590 patients also diagnosed with pericarditis. Pericarditis in the data set was identified using the Safety of Estrogens in Lupus Erythematosus National Assessment – SLE Disease Activity Index (SELENA-SLEDAI), a standard tool in the assessment of SLE clinical activity.
Study results showed that 20% of patients with Lupus who experienced pericarditis had a recurrence. Recurrent pericarditis was most prevalent among patients within the first year of pericarditis onset, with recurrence decreasing in the following years. Younger patients and those with uncontrolled disease were at greater risk of recurrence. It was noted that oral prednisone therapy, a tool frequently used to treat pericarditis in patients with autoimmune diseases, was associated with a higher chance of pericarditis recurrence in patients with SLE.
“The cardiology literature has shown that use of corticosteroids increases the risk of recurrent pericarditis in the general population. Nevertheless, steroids are very frequently used by rheumatologists to treat lupus pericarditis. Therefore, the findings from this study underscore the importance of minimizing oral corticosteroid use in patients with lupus and indicate the need for alternative strategies.” said Andrea Fava, M.D., a rheumatologist who specializes in care of patients with lupus and co-senior author of the study.
Other Johns Hopkins researchers who contributed to the study are Yoo Jin Kim, Jana Lovell, Daniel Goldman, and Michelle Petri.
This study was supported in part by NHLBI grants 5K08HLO145108-03 and 1R01HL160716-01, and NHLBI grant T32-HL007227. The Hopkins Lupus Cohort is supported by R01DK134625.
END
New study supports caution regarding use of steroids
2025-02-26
ELSE PRESS RELEASES FROM THIS DATE:
Treatment strategy reprograms brain cancer cells, halting tumor growth
2025-02-26
UCLA scientists have identified a potential new strategy for treating glioblastoma, the deadliest form of brain cancer, by reprogramming aggressive cancer cells into harmless ones.
The findings, published in the Proceedings of the National Academy of Sciences, demonstrate that combining radiation therapy with a plant-derived compound called forskolin can force glioblastoma cells into a dormant state, making them incapable of dividing or spreading.
When tested in mice, the addition of forskolin to radiation prolonged survival, offering a potential new avenue for combating glioblastoma, a disease with limited treatment options and a median ...
Digital program reduces fall risk and boosts strength in older adults
2025-02-26
Researchers at University of California San Diego have revealed promising results from a study evaluating the university’s “Strong Foundations” program, a digitally delivered fall prevention initiative for older adults. The findings, recently published in JMIR-Aging, emphasize the program’s effectiveness in improving posture, balance and strength — key factors in reducing fall risk.
“This study showcases the potential of accessible, online exercise programs to significantly enhance physical function for older adults,” said Ryan Moran, ...
Why brain cancer is often resistant to immunotherapy
2025-02-26
Immunotherapy has revolutionized the treatment of many cancers, but brain tumors such as gliomas remain particularly difficult to treat, in part because they potently suppress immune responses.
New findings from researchers at the Broad Institute of MIT and Harvard and the Dana-Farber Cancer Institute (DFCI) could help make immunotherapies for brain cancer more effective.
The team analyzed almost 200,000 individual immune cells called myeloid cells from tumor samples from patients with glioma, the most common and aggressive type of primary brain cancer. In a new study in Nature, ...
The Obesity Society commends FDA's resolution of obesity drug shortages, calls for enforcement against unauthorized compounding
2025-02-26
ROCKVILLE, MD – The Obesity Society (TOS) acknowledges the U.S. Food and Drug Administration's (FDA) recent announcement declaring the end of shortages for Novo Nordisk's Wegovy and Ozempic; two critical medications in the treatment of obesity and diabetes. This development signifies a pivotal advancement in patient care, ensuring broader access to these essential, FDA-approved therapies.
This announcement follows the agency’s December 19th decision that Eli Lilly’s tirzepatide, marketed as Zepbound for weight loss, was no longer in shortage and it would give compounders 60 to 90 days before putting a stop to their production of the copycat GLP-1s.
During ...
A new path to recovery: Scientists uncover key brain circuit in the fight against cocaine use disorder
2025-02-26
PHILADELPHIA (February 26, 2025) – Imagine a future where the grip of cocaine use disorder can be loosened, where cravings fade, and the risk of relapse diminishes. A new study published in Science Advances, led by Penn Nursing’s Heath Schmidt, PhD, brings this vision closer to reality. The research has identified a critical brain circuit that plays a pivotal role in regulating cocaine-seeking behavior.
Cocaine use disorder casts a long shadow, trapping individuals in a cycle of dependence and leaving limited options for effective treatment. This study delves deep into the brain, offering ...
Problem-based learning helps students stay in school
2025-02-26
Education experts at the University of South Australia are encouraging schools to consider problem-based learning (PBL) in a move to improve engagement and creativity among high school students.
The call follows new Productivity Commission data that shows national school attendance rates over the past year have decreased from 88.8% in Year 7 to 84% in Year 10. Government schools are worst hit, with only 73% of public-school students completing year 12, as compared with nearly 80% in 2017.
New UniSA research demonstrates how hands-on, community-based projects can deliver successful ...
Blood test could lead to better diagnosis and management of ALS
2025-02-26
Please mention in your story that the study is published in Neurology, the medical journal of the American Academy of Neurology.
MINNEAPOLIS — ALS, or amyotrophic lateral sclerosis, can sometimes be difficult to diagnose or to predict how quickly the disease is likely to progress. A new study helps determine which blood tests are best at identifying and monitoring ALS. The study is published in the February 26, 2025, online issue of Neurology®, the medical journal of the American Academy of Neurology.
“Having an effective biomarker can be highly valuable—in addition to helping ...
Drug may prevent some migraine attacks in children and teens
2025-02-26
EMBARGOED FOR RELEASE UNTIL 4 P.M. ET, WEDNESDAY, FEBRUARY 26, 2025
Media Contacts:
Renee Tessman, rtessman@aan.com, (612) 928-6137
Natalie Conrad, nconrad@aan.com, (612) 928-6164
Drug may prevent some migraine attacks in children and teens
MINNEAPOLIS – For children and teens living with migraine, there may be a new preventive treatment, according to a preliminary study released today, February 26, 2025, that will be presented at the American Academy of Neurology’s 77th Annual Meeting taking place April 5–9, 2025, in San Diego ...
Researchers make recommendations for promoting sustainable development in mangrove forest areas
2025-02-26
Although preventing all the consequences of climate change is now impossible, we can adopt policies to mitigate its impact. In a set of policy recommendations produced by the University of Jyväskylä, researchers examine the development of sustainable livelihoods in the Sundarbans, a coastal region of India and Bangladesh that is vulnerable to the impacts of climate change. The Sundarbans is one of the largest threatened mangrove ecosystems, which efficiently store carbon dioxide and protect coastal areas from cyclones.
In a research project funded by the Research Council ...
Shark activity in South African reef revealed by citizen scientist scuba divers
2025-02-26
Shark sightings by scuba divers reveal the movements of marine predators throughout the year, according to a study published February 26, 2025 in the open-access journal PLOS One by George Balchin, William Hughes and colleagues at the University of Sussex, U.K., and Aquaplanet Dive Center, South Africa.
Many sharks move through different habitats as they follow food or search for mates. Since they are major predators, they change the shape of the ecosystems they visit. Examining these movements is key to understanding the health of ocean habitats as well as the impacts of human activity, but it is notoriously ...